Psychedelic Therapy Research
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers, Therapeutic Advances in Psychopharmacology (2002), Matveychuk
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy, J. Psychoactive Drugs (2019), Dore.
A consensus statement on the use of ketamine in the treatment of mood disorders. (2017) JAMA Psychiatry. Sanacora G.
The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry. (2018), Wilkinson ST.
Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders. J Psychopharmacol. (2017) Glue P.
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine. (2021), Mitchell, Bogenschutz, Doblin.